Page last updated: 2024-10-27

foscarnet and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

foscarnet has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, R1
Takanashi, K1
Suzuki, D1
Nasu, T1
Uetake, K1
Matsumoto, Y1

Other Studies

1 other study available for foscarnet and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2012, Volume: 54, Issue:2

    Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Child; Cytomegalovirus Retinitis; Drug Therapy, C

2012